top of page

Blue Horizon International

End-to-End Publication Management of BHI’s Manuscript in Frontiers in Medicine

Customer

Cytena_edited.png

Description

Blue Horizon International (BHI) is a global leader in stem cell production, currently pursuing U.S. regulatory approval for its cell therapy.

Published in Q1 Journal; Frontiers in Medicine

1500 content downloads